A Cost-Effectiveness Analysis of Prescribing Strategies in The Management of Gastroesophageal Reflux Disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (80)
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
1999 • 3,031 citations
Symptomatic gastroesophageal reflux: Incidence and precipitating factors
1976 • 895 citations
Nissen Fundoplication for Gastroesophageal Reflux Disease
1986 • 864 citations
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
1988 • 792 citations
Economic foundations of cost-effectiveness analysis
1997 • 756 citations
A Comparison of Five Maintenance Therapies for Reflux Esophagitis
1995 • 549 citations
Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and Safety
1994 • 439 citations
The Impact of Gastroesophageal Reflux Disease on Health-related Quality of Life 11Supported by research funding from Astra/Merck, Wayne, Pennsylvania.
1998 • 436 citations
Relevance of Norm Values as Part of the Documentation of Quality of Life Instruments for Use in Upper Gastrointestinal Disease
1996 • 374 citations
Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease
1991 • 354 citations
Screening for Breast Cancer
1989 • 317 citations
Omeprazole or Ranitidine in the Treatment of Reflux Esophagitis: Results of a Double-Blind, Randomized, Scandinavian Multicenter Study
1988 • 277 citations
Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy.
1997 • 267 citations
Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team
1995 • 259 citations
A guide for surveillance of patients with Barrett's esophagus.
1994 • 246 citations
Medical and Surgical Management of Reflux Esophagitis
1975 • 228 citations
Nissen Fundoplication for Gastroesophageal Reflux Disease
1988 • 216 citations
Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial
1988 • 216 citations
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
1996 • 213 citations
Omeprazole as a diagnostic tool in gastroesophageal reflux disease
1998 • 196 citations
Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients.
1997 • 189 citations
Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
1994 • 187 citations
Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis
1988 • 185 citations
Omeprazole or ranitidine in long-term treatment of reflux esophagitis
1994 • 184 citations
Screening for Hypertension
1990 • 180 citations
Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study
1992 • 176 citations
Oesophagitis, Signs of Reflux, and Gastric Acid Secretion in Patients with Symptoms of Gastro-Oesophageal Reflux Disease
1986 • 165 citations
Methodological Aspects of Evaluation of Quality of Life in Upper Gastrointestinal Diseases
1993 • 161 citations
Cost effectiveness of detecting Barrett's cancer.
1996 • 152 citations
Fate of Nissen fundoplication after 20 years. A clinical, endoscopical, and functional analysis.
1993 • 151 citations
Nissen Fundoplication for Reflux Esophagitis Long-Term Clinical and Endoscopie Results in 109 of 127 Consecutive Patients
1993 • 144 citations
Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients.
1994 • 142 citations
Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine
1999 • 139 citations
Patient Satisfaction Following Laparoscopic and Open Antireflux Surgery
1995 • 138 citations
Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection
1996 • 138 citations
Ambulatory 24-Hour pH-Metry in the Diagnosis of Gastroesophageal Reflux Disease
1990 • 136 citations
Benefits and Costs of Screening and Treatment for Early Breast Cancer
1995 • 127 citations
Daytime gastro-oesophageal reflux is important in oesophagitis.
1987 • 125 citations
Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.
1990 • 124 citations
Barrett's Esophagus — Pathophysiology, Diagnosis, and Management
1986 • 122 citations
Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine
1991 • 107 citations
Reliability of 24-hour home esophageal ph monitoring in diagnosis of gastroesophageal reflux
1989 • 105 citations
A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis
1995 • 100 citations
Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis
1996 • 95 citations
Omeprazole is more effective than cimetidine for the relief of all grades of gastro‐oesophageal reflux disease‐associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis
1997 • 93 citations
Idiopathic portal hypertension
1984 • 91 citations
Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.
1990 • 90 citations
Cost and Quality Effects of Alternative Treatments for Persistent Gastroesophageal Reflux Disease
1992 • 89 citations
Long-term Follow-up for Treatment of Complicated Chronic Reflux Esophagitis
1987 • 78 citations
Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
1993 • 75 citations
Lansoprazole versus ranitidine for the treatment of reflux oesophagitis
1995 • 70 citations
The Long Term Results of Open Antireflux Surgery in A Community-Based Health Care Center
1999 • 61 citations
Barrett's esophagus : pathophysiology, diagnosis, and management
1985 • 60 citations
Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
1997 • 54 citations
Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease
1991 • 54 citations
Medicare RBRVS : the physicians' guide
2010 • 52 citations
Study of 47 consecutive patients with peptic esophageal stricture compared with 3880 cases of reflux esophagitis
1992 • 52 citations
Maintenance Treatment for Gastro-Oesophageal Reflux Disease: A Placebo-Controlled Evaluation of 10 Milligrams Omeprazole Once Daily in General Practice
1997 • 52 citations
12 Cost-effectiveness of hormone replacement therapy after the menopause
1991 • 47 citations
Gastro-oesophageal reflux before and after vertical banded gastroplasty in the treatment of obesity.
1996 • 44 citations
Short-Term Treatment of Refractory Reflux Esophagitis with Different Doses of Omeprazole or Ranitidine
1992 • 40 citations
Long-Term Treatment of Gastro-Oesophageal Reflux Disease with Omeprazole
1994 • 35 citations
[Effect of elevated head position in bed in therapy of gastroesophageal reflux].
1996 • 30 citations
Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi‐centre double‐blind study
1997 • 25 citations
Proton Pump Inhibitors Versus H2-Receptor Antagonists for the Treatment of Erosive Gastroesophageal Reflux Disease: A Cost-Comparative Study
1995 • 24 citations
Efficacy of Omeprazole in Lower Grades of Gastro-Oesophageal Reflux Disease
1994 • 19 citations
Nissen fundoplication for gastro-oesophageal reflux disease: long-term results.
1995 • 19 citations
Effect of Smoking in a Controlled Study of Ranitidine Treatment in Gastroesophageal Reflux Disease
1987 • 18 citations
Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package
1995 • 18 citations
Omeprazole vs Ranitidine in Reflux Oesophagitis in Sweden
1994 • 14 citations
New information relevant to long‐term management of endoscopy‐negative reflux disease
1997 • 12 citations
Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease
1992 • 11 citations
Outcome of erosive reflux esophagitis after Nissen fundoplication
1999 • 10 citations
An evaluation of utility measurement in Gastro-esophageal reflux disease (GERD)
1998 • 10 citations
Health economics of gastroesophageal reflux disease.
1997 • 10 citations
Use of Octreotide in the Acute Management of Bleeding Esophageal Varices
1997 • 9 citations
The long term results of open antireflux surgery in a community-based health care center
1999 • 8 citations
Technical and interpretive differences in the analysis of lower esophageal sphincter (LES) pressures
1998 • 1 citations
Five-year follow-up of patients after Laparoscopic Nissen fundoplication
1998 • 1 citations
FRIDAY 23RD SEPTEMBER
1994 • 1 citations